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Spectroscopic characterization, antimicrobial activity and Molecular Docking 
Study of novel azo-imine functionalized sulphamethoxazoles 
 
Nilima Sahu, Sudipa Mondal , Kaushik Naskar, Anyna Das Mahapatra, Suvroma Gupta, 
Alexandra M. Z. Slawin , Debprasad Chattopadhyay and Chittaranjan Sinha* 
 
Sulfamethoxazolyl-azo-imine derivatives (1, 2a-f) have been examined against gram positive 
bacteria, B. subtillis and gram negative E. coli and have found effective selectively on B. 
subtillis
. 
Some of them also show antiviral activity against HSV-1Finfection. The structures of 
the compounds are supported by different spectroscopic data and single crystal X-ray structure of 
2c. The compounds have been docked in the DHPS protein cavity to examine their binding 
strength and 2c shows highest binding strength.  
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Abstract 
[SMX-N=N-C6H3-(p-OH)(m-CHO)] (1) reacts with ArNH2 to synthesize Schiff bases, [SMX-
N=N-C6H3-(p-OH)(m-HC=N-Ar)]  (Ar = –C6H5 (2a), –C6H4-p-CH3 (2b),  –C6H4-p-OCH3 (2c), –
C6H4-p-Cl (2d), –C6H4-p-NO2 (2e), –C10H7 (2f)) and the products have been assessed for 
antibacterial properties against Gram positive bacteria, B. subtillis : IC50 (µg/ml) : 39.2 (1), 60.1 
(2a), 64.0 (2b), 85.6 (2c), 55.1 (2d), 88.4 (2e) and 65.1 (2f);  and Gram negative bacteria, E. coli: 
IC50 (µg/ml) : 159.0 (1), 151.4 (2a), 155.3 (2b), 140 (2c), 156.0 (2d), 153.5 (2e) and 157 (2f).  
The cell line toxicity (Vero cells) has also been evaluated with these compounds and EC50 
(µg/ml) values are 129.9 (1), 74.2 (2a) and 93.0 (2b), 191.9 (2c), 99.1 (2d), 93.2 (2e) and 62.0 
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(2f). The anti-viral efficiency against harpies virus (HSV-1F ATCC-733) infection demonstrates 
that the compound 1 has highest selectivity index (CC50/EC50), 5.06 than the compounds 2a-f 
(CC50/EC50 : 1.18 (2a), 1.42 (2b), 3.50 (2c), 1.45 (2d), 1.58 (2e), 1.29 (2f)). The compounds 
have been spectroscopically characterized and the structural confirmation has been established in 
one case by single crystal X-ray diffraction studies of 2c. In silico Molecular Docking study has 
been done using optimized geometries of the compounds to search the most favored binding 
mode of these drugs and hence useful to explain their competitive drug efficiency. 
Keywords: Schiff base of SMX-N=N-salicylaldehyde, X-ray structure, antimicrobial activity, 
cell line toxicity, molecular docking, DFT.  
 
1. Introduction 
Dr. Paul Ehrlich synthesized arsphenamine (known as salvarsan) in 1907 and used as 
antisyphilitic drug since 1909 [1]. Dr. Paul discovered an azo dye, Prontosil, in 1932 which 
resembles the structure to salvarsan and used as less toxic more efficient drug against syphilis 
[2]. It has been noticed that in the human body prontosil is converted to sulphanilamide which is 
the real active compound. Thus the sulfa drugs or Sulfonamides were discovered. Since 1968, 
clinical use of the antibiotic has dramatically increased.  
 
Sulfonamides inhibit DHPS (dihydropteroate synthetase) in the catalytic participation of 
the condensation of p-aminobenzoic acid (PABA) with 6-hydroxymethyl-dihydropterin 
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diphosphate (DHPS) due to its analogous structure [3]. Sulfamethoxazole (SMX), a common 
antibacterial agent against gram positive and gram negative bacteria, is most often used as part of 
the synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole [4].  Prolong 
administration of SMX may cause toxicity like gastrointestinal upset, skin rashes, breathing 
trouble, add to the kidney damage and stomach or abdomen pain, nausea, headache [5-8]. The 
hypersensitivity arises due to oxidative metabolite such as SMX-hydroxylamine (SMX-NHOH) 
and SMX-nitroso (SMX-NO) [9]. In search of more effective and low toxic drugs the chemical 
and biological modification of antibiotics has taken tremendous momentum in the area of 
synthetic and pharmaceutical chemistry [10]. Azo compounds show a variety of interesting 
biological activities such as, anti-neoplastics, anti-diabetics, anti-septics, anti-HIV and other 
useful chemotherapeutic properties [11]. During last couple of years we have designed some 
sulfonamide derivatives incorporating imine (-C=N-) [12, 13] and azo (-N=N-) [14, 15] 
functions and the compounds have been used to investigate their antimicrobial activity. In this 
work, we have characterized hitherto unknown azo-imine (-N=N-C=N-) functionalized 
sulfamethoxazole (Scheme 1) and their antibacterial and antiviral activity have been examined. 
Out of various functional groups the azo-imine function is pi-acidic and monitors the 
electrochemical potential of the molecules [16]. The drug activity and toxicity of the compounds 
have been scrutinized in this work and the molecular docking studies have been adopted with 
DHPS protein (obtained from PDB source) and DNA to examine their binding at best pose 
condition of the compounds.  
2. Experiment 
2.1. Materials and methods 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
Sulfamethoxazole was purchased from Hi-Media. Sodium nitrite, sodium hydroxide, were 
available from S.D. Fine Chem. Ltd. Salicylaldehyde, aniline, p-toluidine, p-anisidine, p-
chloroaniline, p-nitroaniline and α-naphthylamine were purchased from Sigma-Aldrich. Other 
chemicals and solvents of Analytical grade were obtained from Merck. The solvent was purified 
by standard procedure [17].  
Microanalytical data (C, H, and N) were collected on Perkin–Elmer 2400 CHNS/O elemental 
analyzer. Spectroscopic data were obtained using the following instruments: UV–Vis spectra by 
Perkin–Elmer UV–Vis spectrophotometer model Lambda 25; FTIR spectra (KBr disk, 4000–400 
cm_1) by Perkin–Elmer FT-IR spectrophotometer model RX-1; the 1H NMR spectra by Bruker 
(AC) 300/500 MHz FTNMR spectrometer. ESI mass spectra were recorded on a micro mass Q-
TOF mass spectrometer (serial no. YA 263).   
2.2. Synthesis of azo/imine functionalized sulfonamides 
2.2a.4-(3-Formyl-4-hydroxy-phenylazo)-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide (1) 
The sulfamethoxazolyl diazonium (SMX-N=N-+) ion was prepared by dropwise addition 
of ice cold  aqueous solution of sodium nitrite (0.136 g, 1.97 mmol) to HCl solution (3N, 18 ml) 
of sulfamethoxazole (0.5 g, 1.97 mmol) for 30 min. SMX-N=N-+Cl- so formed was added to the  
ice cold sodium hydroxide (2.4 g) solution of salicylaldehyde (0.20 ml, 1.97 mmol) with 
continuous stirring and pH 7 was maintained to settle yellow precipitate. It was filtered and 
dried. The product was crystallized from aqueous methanol solution; purity was checked by TLC 
and purified by column chromatography (silica gel, 60-120 mesh) and the desired product was 
obtained with (1/10 v/v, CH3CN/toluene) eluent. The yield of 1 was 60%. 
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Microanalytical data, SMX-N=N-C6H3(p-OH)(m-CHO), 1; Mp. 223(2)°C (C17H14N4O5S) : 
Calcd. C, 52.84; H, 3.62 ; N, 14.50; Found   C, 52.78; H, 3.70 ; N, 14.61%.  Mass (m/z), (M+H)+, 
387.07 (Supplementary Materials, Fig. S1). FT-IR spectrum, νmax (cm-1) : 1084,  ν(C-O);  
1476,  ν(N=N);  1659,  ν(C=O); 1618, ν(C-N); 3345, ν(O-H); 1170, ν(S-O) (Supplementary 
Materials, Fig. S2). 1H NMR spectrum, (CDCl3) δ(17-CH3)(oxazole), 2.38 (s);  δ(O-H), 11.43 
(s); δ(N-H), 6.26 (s) , δ(CHO) 10.04 (s);  δ(4-H), 7.12 (d, J = 9.21 Hz); δ(7-H), 7.25 (s); δ(5-H), 
8.20 (d, J = 8.22 Hz), δ(10,12-H), 7.98 (m); δ(9,13-H), 8.02(m); δ(16-H), 8.17 (s) ppm 
(Supplementary Materials, Fig. S3). 
 
2.2b. Azo sulfonamide Schiff bases, SMX-N=N-C6H3(p-OH)(m-CH=N-Ar), (Ar = – C6H5 
(2a), – C6H4 –p-CH3 (2b),   – C6H4 –p-OCH3 (2c),– C6H4 -p-Cl (2d), – C6H4 –p-NO2 (2e), -
C10H7  (2f)) 
The hot methanol solution of 1 (0.1 g, 0.26 mmol) was refluxed with 1:1 molar ratio (0.30 mmol) 
of aromatic Ar-NH2 (0.30 mmol) (Ar = – C6H5 (2a), – C6H4 –p-CH3 (2b),   – C6H4 –p-OCH3 
(2c),– C6H4-p-Cl (2d),– C6H4 –p-NO2 (2e), -C10H7  (2f)) for 10 to 24 h. The solution was then 
allowed to evaporate slowly in air and orange yellow crystals were deposited on glass wall. The 
crystals were collected and TLC test was performed to check purity. The product was 
recrystallized from methanol solution. The yield was 55-75 %.  
Microanalytical data, SMX-N=N-C6H3(p-OH)(m-CH=N-C6H5), C23H19N5O4S (2a) (yield, 68%), 
Mp. 232°C (C23H19N5O4S) : Calcd. C, 59.86; H, 4.15 ; N, 15.18; Found   C, 59.78; H, 4.19; N, 
15.30%.  Mass (m/z), (M+H)+ (462.2) (Supplementary Materials, Fig. S4). FT-IR spectrum, 
νmax (cm-1) : 1101,  ν(C-O); 1472, ν(N=N); 1618, ν(C=N); 3450, ν(O-H); 1174, ν(SO2) 
(Supplementary Materials, Fig. S5); ); 1H NMR spectrum (CDCl3) δ(17-CH3)(oxazole) 2.38 
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(s);  δ(16-H), 8.07 (s); δ(O-H), 14.10 (s); δ(N-H), 6.26 (s); δ(CH-N) 8.75 (s); δ(7-H), 8.07 (s); 
δ(5-H), 7.97(s); δ(4-H), 7.16 (d, J = 8.85 Hz); δ(10,12-H), 7.26 (m); δ(9,13-H), 7.31 (m); δ(20-
24-H), 7.44(m) ppm (Supplementary Materials, Fig. S6) 
SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-CH3), C24H21N5O4S (2b) (yield, 65%),: Mp. 247°C: 
Calcd. C, 60.62; H, 4.45; N, 14.73; Found C, 60.56; H, 4.40; N, 14.77 %.  Mass (m/z), 
(M+H)+(476.15) (Supplementary Materials, Fig. S7). FT-IR spectrum, νmax (cm-1):1091, ν(C-
O); 1472, ν(N=N); 1618, ν(C=N); 3390, ν(O-H); 1174, ν(S-O) (Supplementary Materials, Fig. 
S8). 1H NMR spectrum (DMSO-D6) δ(17-CH3)(oxazole), 2.29 (s); δ(16-H), 8.31 (s); (22-CH3), 
2.33 (s);  δ(O-H), 10.21 (s); δ(N-H), 6.16 (s); δ(CH-N), 9.16 (s);  δ(4-H), 7.15 (d, J = 8.9 Hz); 
δ(5-H), 7.30 (d, J = 7.97 Hz); δ(10,12-H), 7.41 (m); δ(9,13-H), 7.38 (m); δ(16-H), 8.31 (s); δ(4-
H of phenyl) and 8.02 (s); δ(20-24-H), 7.30 ppm (m) (Supplementary Materials, Fig. S9). 
SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-OCH3), C24H21N5O5S (2c) (yield, 73%),: Mp. 235°C: 
Calcd. C, 58.65; H, 4.31 ; N, 14.25; Found   C, 58.58; H, 4.26; N, 14.18%.  Mass (m/z), (M+H)+( 
492.2) (Supplementary Materials, Fig. S10). FT-IR spectrum, νmax ( cm-1) : 1091, ν(C-O); 
1489, ν(N=N); 1616, ν(C=N); 3378, ν(O-H); 1174, ν(S-O) (Supplementary Materials, Fig. 
S11). 1H NMR spectrum (DMSO-d6) δ(17-CH3)(oxazole), 2.22 (s);  (22-O-CH3-phenyl), 2.48 
(s); δ(16-H), 8.29 (s);  δ(O-H), 11.40 (s); δ(N-H), 6.15 (s); δ(CH-N) 9.15 (s);  δ(4-H), 7.03 (d, J 
= 5.65 Hz); δ(5-H), 7.11 (d, J = 8.76 Hz); δ(7-H), 7.14 (s); δ(9,13-H), 7.51 (m); δ(10,12-H) 8.02 
(m); δ(20, 24-H), 7.42 (m); δ(21,23-H), 7.17 (m) ppm  (Supplementary Materials, Fig. S-12). 
SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-Cl), C23H18N5O4ClS (2d) (yield, 74%),: Mp. 238°C 
Calcd. C, 55.70; H, 3.66; N, 14.12; Found   C, 55.63; H, 3.60; N, 14.21%.  Mass (m/z), (M+H)+, 
(496.8) (Supplementary Materials, Fig. S13). FT-IR spectrum, νmax (cm-1) :1093, ν(C-O); 1505, 
ν(N=N); 1621, ν(C-N); 3443, ν (O-H); 1180, ν(S-O) (Supplementary Materials, Fig. S14). 1H 
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NMR spectrum (DMSO-d6) δ(17-CH3)(oxazole) 2.28 (s); δ(16-H), 8.35 (s);  δ(O-H), 13.80 (s); 
δ(N-H), 6.16 (s); δ(CH-N) 9.15 (s);  δ(4-H), 7.19 (d, J = 8.94 Hz); δ(5-H), 7.50 (m); δ(9,13-H), 
7.47 (m); δ(10,12-H) 7.98 (s); δ(21,23-H), 7.15 (m); δ(7-H), 8.35 (s); δ(20,24-H), 7.45 (m) ppm  
(Supplementary Materials, Fig. S-15).  
SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-NO2), C23H18N6O6S (2e) (yield, 55%),: Mp. 185°C: 
Calcd. C, 54.54; H, 3.58; N, 16.59; Found C, 54.48; H, 3.66; N, 16.68%.  Mass (m/z), (M+H)+ 
(507.5) (Supplementary Materials, Fig. S16). FT-IR spectrum, νmax (cm-1): 1099, ν(C-O); 1473, 
ν(N=N); 1613, ν(C-N); 3393, ν(O-H); 1174, ν(S-O) (Supplementary Materials, Fig. S17). 1H 
NMR spectrum (DMSO-d6) δ(17-CH3)(oxazole), 2.37(s); δ(16-H), 8.26 (s); δ(O-H), 11.42 (s); 
δ(N-H), 6.25 (s); δ(CH-N) 10.03 (s); δ(4-H), 7.43 (d, J = 8.13 Hz); δ(5-H), 7.80 (d, J = 8.07 Hz); 
δ(7-H), 7.86 (s); δ(10,12-H), 7.12 (m); δ(9,13-H), 7.41 (m); δ(20, 24-H), 7.57 (m); δ(21,23-H), 
8.02 (m) ppm (Supplementary Materials, Fig. S18). 
SMX-N=N-C6H3(p-OH)(m-CH=N-(α)-C10H7), C27H21N5O4S, (2f) (yield, 64%), Mp. 130°C 
Calcd. C, 63.39; H, 4.14; N, 13.69; Found   C, 63.25; H, 4.06 ; N, 13.77%.  Mass (m/z), (M+H)+, 
(512.4) (Supplementary Materials, Fig. S19). FT-IR spectrum, νmax (cm-1): 1106, ν(C-O); 1467, 
ν(N=N); 1607, ν(C=N); 3387, ν(O-H); 1175, ν(S-O) (Supplementary Materials, Fig. S20);  1H 
NMR spectrum, (DMSO-d6) δ(17-CH3)(oxazole), 2.48 (s); δ(16-H), 8.15 (s); δ(O-H), 13.9 (s); 
δ(N-H), 6.15 (s); δ(CH-N), 9.21 (s);  δ(4-H), 7.20 (d, J = 8.83 Hz); δ(5-H), 7.60 (d, J = 7.7 Hz); 
δ(7-H), 7.50 (s); δ(10,12-H), 7.90 (m); δ(9,13-H), 8.20 (m); δ(Hs of naphthyl) 7.75-7.96 (m) 
(Supplementary Materials, Fig. S-21). 
 
2.3. X-Ray crystal structure analysis of SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-OCH3), 
(2c) 
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 The crystals of 2c were obtained by slow evaporation of methanol solution (0.12 x 0.10 x 0.02 
mm3) for a week. Data were collected by Bruker Smart CCD Area Detector at 173(2) K with θ 
in the range 2.429° ≤ θ ≤ 25.35°. Fine-focus sealed tube was used as the radiation source of 
graphite-monochromatized Mo-Kα radiation (λ = 0.71075 Å). Empirical absorption correction in 
the h k l range: -22 ≤ h ≤ 22, -8 ≤ k ≤ 8, -22 ≤ l ≤ 22 was accomplished with the program 
SADABS [18]. Crystallographic refinement data are collected in Table 1. Multi-scan absorption 
corrections were applied [19]. The structure was solved by direct methods with SHELXL-97 [20] 
and refined by full-matrix least-squares techniques on F2 using the SHELXS-97 [21] program 
with anisotropic displacement parameters for all non-hydrogen atoms. The ORTEP-3 [22] was 
used within WinGX to prepare figures and tables for publication. Hydrogen atoms were 
constrained to ride on the respective carbon atoms with isotropic displacement parameters equal 
to 1.2 times the equivalent isotropic displacement of their parent atoms in all cases of aromatic 
units. Residual minimum and maximum electron densities are -0.350 and 0.440. 
2.4. Antimicrobial activity  
 [SMX-N=N-C6H2-(p-OH)(m-CHO)] (1) and its six derivatives SMX-N=N-C6H3(p-OH)(m-
CH=N-C6H5) (2a), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-CH3) (2b), SMX-N=N-C6H3(p-
OH)(m-CH=N-C6H4-p-OCH3) (2c), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-Cl) (2d), SMX-
N=N-C6H3(p-OH)(m-CH=N-C6H4-p-NO2) (2e), SMX-N=N-C6H3(p-OH)(m-CH=N-(α)-C10H7) 
(2f) were tested against gram positive, B. subtillis (ATCC 6633) and gram negative, E. coli 
(ATCC 8739) bacteria. The compounds were dissolved in HPLC grade DMSO; final % of 
DMSO during assay was varied from 0.5-0.8% although the main stocks of the drugs were 
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Table 1:  Crystal data and structure refinement of SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-
OCH3) (2c) 
 2c 
Empirical formula C24H21N5O5S 
Formula weight 491.52 
Temperature (K) 173
 
Crystal system Monoclinic 
 Space group  P2/c 
a(Å) 18.285(5) 
b(Å) 6.8187(16) 
c(Å)  18.507(5) 
β (°)  103.745(4) 
V(Å)3  2241.4(10) 
Z  4 
µ (MoKα) (mm-1)  0.71075 
θ range  2.29 – 25.35 
Dcalc (mg m-3) 1.456 
Refine parameters 324 
Total reflections  4084 
Unique reflections 21015 
R1a [ I > 2σ (I) ] 0.0497  
wR2b  0. 1190 
GOFc 1.083 
aR= ΣF0 –Fc / Σ F0 .  bwR =[Σ w(F02 – Fc2)/ Σ w F04]1/2 are general but w are different, w = 1/ 
[σ2 (Fo2) + (0.0508P)2 +1.7997P] where P=(Fo2+2Fc2)/3 
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prepared using spectroscopic grade DMSO and stored at -20°C. All the bacterial strains were 
inoculated in a freshly prepared autoclaved LB broth from a 24 hours old LA slant and kept in 
shaker for overnight. From the overnight culture it was diluted to a final bacterial count of 1x 104 
cells /ml with sterile LB. The diluted culture was distributed in a number of tubes and incubated 
in absence as well as in presence of various concentrations of test compounds. All the tubes were 
incubated for 16-18 hours at 37°C in shaking condition. The OD600 had been measured in a UV 
visible spectrophotometer (Shimadzu). The OD value observed in absence of test ligand had 
been considered as control with 100 % growth for both the bacterial species. Compared to 
control the relative degree of bacterial growth inhibition had been calculated for each 
concentration incubated under similar experimental condition from a measurement of OD at 600 
nm. The minimum inhibitory concentrations (IC50) i.e. the concentration of test compound 
required to inhibit the growth of bacteria by 50 % had been calculated from the % reduction of 
bacterial growth in comparison to control.  
2.5. MTT assay 
Vero cells (African green monkey kidney cells; ATCC, Manassas, VA, USA) were cultured in 
Dulbecco's modified Eagle's medium (DMEM) with 5–10% fetal bovine serum (FBS; 
Invitrogen, USA), 100 U ml-1 penicillin and 100 mg ml-1 streptomycin, at 37 0C in 5% CO2. The 
viral strains used were HSV-1F (ATCC 734), purchased from the ATCC (Manassas, VA, USA). 
Virus stocks were prepared from infected culture at a multiplicity of infection (MOI) of 0.5 to 1 
h at 37°C. The residual viruses were then washed out with phosphate-buffered saline (PBS) and 
the cells were cultured for another 48–72 h. The cultured cells were lysed finally by three cycles 
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of freezing and thawing, centrifuged at 4°C for 20 min and the collected supernatant was tittered 
by plaque assay, and stored at -80°C for further studies. 
The effect of compounds on African green monkey kidney cells (Vero cell) morphology 
was determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide) assay 
following the manufacturer's instruction (MTT 2003, Sigma-Aldrich). Vero cells were cultured 
onto 96-well plates at 10 ×106 cells per well, and different concentrations of the compounds (1, 
2) were added to each well at a final volume of 100 µl, in triplicate using DMSO (0.1%) and 
acyclovir (0–50 µg ml-1 ) as a negative and positive control, respectively. The drug-treated cells 
were incubated at 37°C with 5% CO2 for 2 days, and then the MTT reagent (10 µl) was added to 
each well. After 4 h of incubation, the formazan was solubilized by adding MTT solubilisation 
solution equal to the original culture media volume, and the absorbance was read at 570 nm with 
a reference wavelength of 690 nm by an ELISA reader. Data were calculated as the percentage 
of cell viability by the formula: [(sample absorbance cell free sample blank)/mean media control 
absorbance)]/100%. The 50% cytotoxic concentration (CC50) causing visible morphological 
change in 50% of Vero cells with respect to cell control was determined [23, 24].   
 2.6. Anti-HSV Activity 
 
Dose response analysis of test compounds on virus infected cell was done to observe the 
viral activity. Vero cells seeded in 96 well plates were infected with HSV-1F at 1 MOI and 
exposed to the various concentrations of 1 and 2 and acyclovir (standard drug). The dose-
dependent antiviral activity was evaluated by MTT assay to determine the inhibition of infection, 
as described previously [25, 26]. Values were obtained from three independent experiments with 
each sample performed in triplicate. 
 
2.7. Theoretical Calculation: DFT and Docking studies 
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The geometry optimization of 1 and 2a-f were carried out using Density Functional 
theory (DFT) at the B3LYP level [27]. All calculations were carried out using the Gaussian 09 
program package [28] with the aid of the GaussView visualization program [29]. For C, H, N, O 
the 6-31G (d) basis set were assigned. The vibrational frequency calculations were performed to 
ensure that the optimized geometries represent the local minima and there are only positive eigen 
values. Vertical electronic excitations based on B3LYP optimized geometries were computed 
using the time-dependent density functional theory (TD-DFT) formalism in methanol using 
conductor-like polarizable continuum model (CPCM) [30 – 32] Gauss Sum was used to calculate 
the fractional contributions of various groups to each molecular orbital [33]. 
The crystal structure of DHPS (Dihydroptorat Synthetase of Versinia pestis, PDB ID 
3TZF) was downloaded from RCSB protein data bank (http://www.pdb.org) and used for 
docking. The enzyme was co-crystallized with sulfamethoxazole, 6-hydroxymethylpterin-
diphosphate and magnesium ion. The in silico docking studies was carried out by using 
CDOCKER of Receptor-Ligand interactions protocol section of Discovery Studio client  3.5 
[34]. Interaction energies between Ligands and Receptor were recorded. Lipinski’s rule [35] and 
Veber rule [36] were verified and the drugs were passed though ADMET for toxicity 
computation.  
The crystal structure of 2c and optimized structures of other compounds (1, 2a-f) have 
been used for docking. Ligand preparation was done using Prepare Ligand module in Receptor-
Ligand interactions tool of Discovery studio 3.5 and prepared ligand was used for docking. 
Protein preparation was done under Prepare Protein module of Receptor-Ligand interactions tool 
of Discovery Studio 3.5 and that was used for docking. The active site was selected based on the 
ligand binding domain of sulfamethoxazole then the pre-existing ligand was removed and 
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prepared ligand, was placed. Most favorable docked pose was selected according to the 
minimum free energy of protein-ligand complex and analyzed to investigate the interaction. 
Absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction were done in 
ADMET descriptor module of Small molecules protocol of Discovery studio client 3.5. 
Druglikeness of the compounds used in this work was checked following Lipinski’s rule of five 
[35]. Using ADMET module of small molecule protocol of Discovery studio 3.5 software 
ADMET properties and toxicity of the compounds were checked.  
3. Results and discussion 
3.1. Synthesis and spectroscopic characterisation   
4-(3-Formyl-4-hydroxy-phenylazo)-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide 
[SMX-N=N-C6H3-(p-OH)(m-CHO)] (1) reacts with aromatic amines, p-R-C6H4-NH2, to 
synthesize SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-R)) (R = H (2a), -CH3 (2b), -OCH3 (2c), -
Cl (2d), -NO2 (2e), -α-naphthyl (2f)).  Disappearance of ν(CHO) at 1659 cm-1 of 1 in the FT-IR 
spectra of the products, 2, and the emergence of strong stretch at 1610 – 1625 cm-1 refer to 
ν(HC=N) are in support of the condensation reaction. Other significant stretches such as 
ν(N=N), 1470-1480; ν(C-O), 1090–1110; ν(SO2), 1170-1180 cm-1 support the synthesis of the 
compounds 2 (Supplementary material, Fig. S2, S5, S8, S11, S14, S17, S20). The mass spectra 
identify the molecular ion peak which also support the calculated m/z and have established the 
isolation of 2. All the compounds show absorption bands at 350-370 nm and 270-290 nm due to 
n-pi* and pi-pi* transitions, respectively (Fig. 1). The 1H NMR spectra are convoluted due to large 
number of proton signals from aromatic rings (atom numbering is given in the structures, 
Scheme 1); however significant singlet signals are oxazolyl-CH3 (2.45-2.50 ppm), δ(OH) (11.40 
– 11.50 ppm), δ(NH) (6.10 – 6.20 ppm); δ(CH=N), 9.10 – 9.20 ppm. Oxazolyl-H (16-H, singlet)  
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Scheme 1. Synthesis of SMX-azo-imine derivatives; SMX-N=N-C6H3(p-OH)(m-CHO) (1), 
SMX-N=N-C6H3(p-OH)(m-CH=N-C6H5) (2a), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-CH3) 
(2b),  SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-OCH3) (2c), SMX-N=N-C6H3(p-OH)(m-
CH=N-C6H4-p-Cl) (2d), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-NO2) (2e), SMX-N=N-
C6H3(p-OH)(m-CH=N-(α)-C10H7) (2f). 
appears at 8.29-8.31 ppm and sulfonamide-phenyl-Hs (9,10,12,13-H) become visible as two 
doublets at 7.35 – 7.45 ppm. Azophenolato-H such as 7-H is a singlet at 7.10-7.15 ppm while 
4,5-H show doublet signal at 7.10 – 7.30 ppm. The terminal six member ring, arylamine has four 
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or five-Hs and have shown noteworthy signal movement due to substituent effect; electron 
donating –CH3 and -OCH3 influence 21,23-H to shift to upfield side while electron withdrawing 
groups –Cl and –NO2 influence them to move to downfield side (Supplementary  material, Fig. 
S12, S18). The single crystal X-ray structure of 2c also confirms the structural proposal from 
other spectroscopic information. 
 
Fig. 1. Electronic spectra of the compounds, 1 and 2a-f in methanol solution  
 
3.2. Molecular structure of 2c  
An ORTEP view of 2c is shown in Fig. 2.  The selected bond lengths and angles are 
given in Table 2. The structure is sub-divided into four parts for brevity; imine phenolato (A-
ring), aryl-sulfonamide (B-ring) oxazolyl (C-ring), methoxy substituted phenyl (D ring). The C-
ring is linked to B-ring by the sulfonamide (-NH-SO2-) group and the B-ring is connected to A-
ring by –N=N- group and A ring is attached to D -ring by -HC=N- group. The -C6H3(OH)- (A-
ring) and -C6H4(SO2)-) (B-ring) are bonded to –N=CH- with dihedral 15.88(13)°; oxazolyl ring  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
 
Fig. 2. ORTEP structure (30% ellipsoid) and hydrogen bonded 1D chain followed by pi---pi 
interaction to build 2D network (aromatic rings are marked : A, imine phenolato ring; B, aryl-
sulfonamide ring; C, oxazolyl ring; D, methoxy substituted phenyl ring). 
(C-ring) is inclined at 88.16(17)° with B-ring. The, N=N, azo length is 1.261(3) Å and the, C=N, 
imine length is 1.289(3) Å and these are closer to the reported data [12-15].  An intramolecular 
hydrogen bond -N=N-C6H3O–H---N-C6H4-p-OCH3 i.e. (O–H---N), ∠O(15)–H(15)---N(19), 
154.48(2)°; H(15)---N(19), 1.659(4) Å; O(15)---N(19), 2.580(4) Å) improves the bonding 
strength in the molecule. Two adjacent molecules constitute a dimer of eight-member supracycle 
through intermolecular hydrogen bonds  N(19)-H(15), 2.580 Å. These dimers are then hydrogen 
bonded to consititue 1-D chain via N(2)-H(3), 1.926 Å. Two aryl rings, imine phenolato (A-ring) 
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of two adjacent molecules show cross pi---pi interaction, A---B, 4.02 Å (Fig. 2). In the expanded 
structure both intramolecular and intermolecular hydrogen bonds constitute 2D plane. Hydrogen 
bonded centres are –O-CH3, -OH, -SO2-NH-, azo-N, oxazolyl-N, phenyl-Hs, -CH3 group in 
oxazolyl motif.  
The optimized structure generated by DFT computation using Gaussian09 package for 2c 
has been verified from the bond parameters with experimentally determined single crystal X-ray 
structure (Fig. 2, Table 2). Theoretically generated bond parameters such as N(9)–N(12) (1.248 
Å), C(9)-N(9) (1.459 Å), C(6)-S(1) (1.790 Å), differ by 0.004-0.03 Å and the bond angles 
∠N(9)–N(12)–C(12), 107.5°; ∠N(12)–C(12)–C(17), 119.9°; ∠O(4)–S(1)–C(6), 109.5° differ by 
2-4°. This closeness in the metric parameters supports high agreement in the calculated 
molecular functions of the molecule.   
Table 2: Selected bond lengths and bond angles of 2c 
 
3.3. Antimicrobial activity 
SMX-N=N-C6H3(p-OH)(m-HC=N-C6H4(p-OCH3)) (2c) 
Bond length (Å) Bond Angle (°) 
 X-Ray DFT   X-Ray DFT  
N(9)–N(12) 1.261(3) 1.248 N(9)–N(12)–C(12) 114.4(2) 107.5 
C(9)-N(9) 1.425(3) 1.459 C(9)–N(9)–N(12) 112.9(2) 107.4 
C(12)-N(12) 1.416(3) 1.390 N(12)–C(12)–C(17) 124.9(2) 119.9 
C(18)-N(19) 1.419(3) 1.386 N(9)–C(9)–C(10) 123.7(2) 120.0 
N(19)-C(18) 1.289(3) 1.260 C(18)–N(19)–C(19) 121.4(2) 115.0 
C(6)-S(1) 1.763(2) 1.790 N(19)–C(18)–C(14) 121.1(2) 120.0 
C(9)-C(10) 1.391(3) 1.395 O(4)–S(1)–C(6) 107.8(1) 109.5 
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The interaction of PABA with DHPS is crucial for bacterial folic acid synthesis which is 
being interfered by SMX and is popularly known as antimicrobial activity. During metabolic 
process SMX is oxidized to toxic metabolic products by Cyt P450 and the end products are 
responsible for hypersensitivity and toxicity. The compounds, [SMX-N=N-C6H3-(p-OH)-(m-
CHO)]  (1) and their six Schiff bases SMX-N=N-C6H3(p-OH)(m-CH=N-C6H5) (2a), SMX-N=N-
C6H3(p-OH)(m-CH=N-C6H4-p-CH3) (2b), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-OCH3) 
(2c), SMX-N=N-C6H3(p-OH)(m-CH=N-C6H4-p-Cl) (2d), SMX-N=N-C6H3(p-OH)(m-CH=N-
C6H4-p-NO2) (2e), SMX-N=N-C6H3(p-OH)(m-CH=N-(α)-C10H7) (2f) have been tested against 
gram positive, B. subtillis (ATCC 6633) and gram negative, E. coli (ATCC 8739) bacteria. The 
OD value (600 nm) observed in absence of test ligand and had been considered as control with 
100 % growth for both the bacterial species. The minimum inhibitory concentrations (IC50) i.e. 
the concentration of test compound required to inhibit the growth of bacteria by 50 % for 1 and 2 
have been tested against B. subtillis (ATCC 6633) and E. coli (ATCC 8739) (Table 3). Data 
reveal that Schiff bases 2 are less potent than that of the precursor aldehyde, 1; the reason is 
unknown. However, one may apprehend that –CHO is more polar and less space demanding than 
–CH=N-Ar and may be easily permeable in the cell membrane [37]. The profile of inhibition has 
been presented in Fig. 3. From the result it is evident that the drug molecules produce a 
concentration dependant decrease in the growth of gram positive, B. Subtillis but not in gram 
negative, E.coli.  
3.4. Inhibition of HSV-1F infection 
The cytotoxicity assay of the compounds indicated that 50% drug efficiency (CC50, µg/ml) of the 
drugs are 129.98 (1), 74.36 (2a), 93.01 (2b), 191.97 (2c), 99.1 (2d), 93.18 (2e) and 61.98 (2f). 
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The antiviral effects of each drug is examined against HSV-1-infected Vero cells (MOI 1) by 
MTT assay, using acyclovir as positive and DMSO (0.1%) as negative control. The results reveal 
that the drug 1 could inhibit virus in a dose dependent manner, but the derivatives 2 have shown 
less anti-HSV potential as well as EC50 activity (the 50% effective concentration) for HSV-1. 
The selectivity index (SI), a measure of the preferential antiviral activity of a drug in relation to 
its cytotoxicity (CC50/EC50), of the compounds are 5.06 (1), 1.18 (2a), 1.42 (2b), 3.50 (2c), 1.45 
(2d), 1.58 (2e), 1.29 (2f) and 52.48 (acyclovir) against HSV-1. Thus, the precursor 1 is selected 
as best antiviral compound amongst drugs tested in this work. Acyclovir achieved >99% 
inhibition at 5 mg ml-1 for HSV-1. The result (Fig. 4) has revealed that the drugs 1 and 2a-f have 
inhibited HSV-1 in a dose-dependent manner. The derivatives, 2a-f are inactive as their SI values 
are less than 4 while the precursor 1 is considered as active against HSV infection because of 
Selectivity Index (SI) (CC50/ EC50) is 5.06. 
Table 3: Half-maximal Inhibitory Concentrations (IC50) of 1 and 2 against B. Subtilis and E. coli 
 
 
 
 B. Subtilis  (µg/ml) E. coli (µg/ml) 
SMX 101.0 95.0 
1 39.3 159.0 
2a 60.1 151.4 
2b 64.0 155.3 
2c 85.6 140.0 
2d 55.2 156.0 
2e 88.4  153.5 
 2f 65.2 157.0 
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Fig. 3. Inhibition profile of SMX, [SMX-N=N-C6H3-(p-OH)-(m-CHO)]  (1) and their six 
derivative [SMX-N=N-C6H2-(p-OH)-(m-HC=N-Ar)]  (Ar : – C6H5 (2a), – C6H4-(p-CH3) (2b), – 
C6H4-(p-OCH3) (2c), – C6H4-(p-Cl) (2d), – C6H4-(p-NO2) (2e), -C10H7 (2f) for B. subtillis and 
E. coli 
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 Fig. 4. Half-effective concentration (EC50) and selectivity index (SI) of 1 and 2 against HSV-1F 
infection (The 50% cytotoxicity concentration for Vero cell in µg ml-1, concentration of 
compound (µg ml-1) producing 50% inhibition of virus induced CPE of three separate 
experiments. Selectivity index (SI), CC50/EC50). 
3.5. Theoretical Interpretation by DFT and Docking studies 
The DFT optimized structures or the structure obtained from the single crystal X-ray 
analysis are useful to study protein ligand interaction. The best pose interaction has been 
evaluated by docking score, binding energy and Log P data.  To follow Lipinski’s rule of five, 
(35,36) it is essential to know drug-relevant properties of the ligands. Finally the druglikeness of 
the target molecules has been tested by ADMET to know the molecular properties i.e. 
absorption, distribution, metabolism, excretion and toxicity. The calculated data show the good 
solubility level, moderate absorption stage, seven or eight H-bond acceptors, two H-bond donors 
and follow Lipinski’s filter and Log Ps vary from 3.431 to 6.161 (Table 5). This implies that 
present series of azo-sulfonamids / azo-imino-sulfonamids interact more strongly than that of 
SMX to DHPS protein (Table 4).  The hydrophilic and hydrophobic parts of the derivatives bind 
through hydrogen bonding and different electrostatic interactions [37, 38]. 
Table 4: Iinteractions energy in most stable protein-ligand complex for 1 and 2 
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Data in Table 4 reveal that the C-DOCKER interaction energy of the drugs with 3TZF 
follow the ordering 2b>2f>2a>2c>2e>2d>1; thus the ligand 2b shows fast communication with 
the protein. The steps to the best interaction of the drug-to-protein are the communication to 
surface interaction which follows the binding to penetration into the cavity or pocket and finally 
the chemical and physiological transformation through metabolic process [39]. Hence C-
DOCKER interaction energy trend does not reflect its binding strength; it is the binding energy 
which will reflect the strength of binding. The drug 2c binds to the protein (Table 4), 3TZF@2c 
and shows highest stability (-115.89 Kcal/mol). The interaction proceeds mainly through 
electrostatic path with 3TZF. The drug 1 interacts with 3TZF (3TZF@1) and the amino acid 
residues involve in the interactions are Lys221, Ser 222, Arg255, Arg255. In case of 3TZF@2 
the amino acid residues Ser222, Lys 221, Leu193 for 2a, Gly139, Thr62 for 2b, Gly189 and 
Arg255 (NH to O of OCH3) for 2c, Arg255 for 2d, Thr62 and arg255 for 2e, Arg135 and Gly189 
for 2f are involved in the binding cavity of the protein. Interaction analysis suggests that ligand 1 
Compounds CDOCKER 
interaction 
Energy (a.u.) 
Binding energy 
(Kcal/mol) 
Ligand energy 
(Kcal/mol) 
Protein 
energy 
(Kcal/mol) 
Energy of protein 
ligand complex 
(Kcal/mol) 
3TZF@1 -42.58 -87.47 22.67 -22,831 -22,896 
3TZF@2a  -49.61 -90.31 11.78 -22,831 -22,835 
3TZF@2b  -51.11 -98.91 12.10 -22,831 -22,918 
3TZF@2c -48.89 -115.89 10.64 -22,831 -22,936 
3TZF@2d -42.96 -108.44 19.23 -22,831 -22,920 
3TZF@2e -43.47 -84.23 20.61 -22,831 -22,748 
3TZF@2f -49.90 -104.18 35.48 -22,831 -22,900 
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binds with DHPS of E. coli through oxygen atom of -SO2, oxazolyl moiety, azo-N and form 
recognizable H-bonds (Fig.5). Lys221 NH atom interacts with -C=O of salicyldehyde moiety:  
H--C 1.88 Å and ∠N-H---O, 150°; Ser222-O atom interacts with NH (sulfonamide moiety): O—
H,  2.87 Å and ∠O--H-N, 91°; Arg255 NH---O (salicylaldehyde): N---O,  2.20 Å; ∠N–H---O, 
114°; Arg255 NH---O(salicylaldehyde) : N---O, 2.99 Å; ∠N–H---O, 110o  for 1 (Fig. 5) and 
Leu194 NH---O(SO2) : H---O, 2.10 Å; ∠N–H---O, 145°; Ser222 CH interacts with azo-N, H----
N, 2.69 Å; ∠C–H---N 135o and Lys221 CH atom interacts with N(imine moiety), H---N, 2.69; 
∠C–H---N, 157o. Pro 64 oxazole nucleus involves pi---pi  interaction with salicylaldehyde ring 
(4.36°) for 2a (Fig. 6);  Ser62 OH interacts with salicylaldehyde-O moiety : O---H, 2.02°; ∠H---
HO 142o  of 2b (Fig. 7); Gly189 O atom interacts with OH of salicylaldehyde moiety : O---O,  
3.02 Å; ∠O---O-H, 117°, Arg255 NH atom interacts with O of OCH3 moiety: H---O,  2.03 Å and 
∠N-H---O, 148°)  for 2c (Fig. 8);  Arg135 NH atom interacts with O of oxazolyl moiety: H---O,  
2.83 Å and ∠N-H---O, 121°) for 2d (Fig. 9); Thr62 HN atom  to O of SO2 moiety of SMX H---
O,  2.81 Å; ∠N–H---O, 155°; Thr62 OH atom  to HN of SO2 moiety of SMX : H---N,  2.72 Å 
and ∠O---H-N, 154°; Arg255 NH atom  to O of SO2 moiety of SMX : H---O  2.81 Å, ∠N-H---
O, 142° for 2e (Fig. 10); Arg135 NH atom interacts with O of SO2NH moiety: H---O, 1.98 Å; 
∠N-H---O, 134°, Gly189 O atom interacts with salicylaldehyde-OH moiety: O---O,  2.06 Å; 
∠O---O-H, 152° for 2f (Fig. 11); Aromatic ring of naphthaldehyde of 2f is involved in pi---pi  
interaction with ThrNH (3.17 Å) (Table 6).  
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Table 5: ADMET prediction of the compounds following Lipinski’s filter 
Compd Mol. 
Weight 
ADMET 
Solubility 
(aqueous) 
ADMET 
solubility 
level 
ADMET 
absorption 
level 
ADMET
_Log P 
Molecular 
fractional 
polar 
surface 
area 
No of H-
bond 
acceptor 
No. of 
H- bond 
donor 
Lipniski's 
filter 
Drug 
likeness 
inference 
Ames 
Prediction 
1 386.38 -4.699 2 2 3.343 0.393 7 2 Yes Yes, low Non-
mutagen 
2a 462.20 -6.034 2 2 3.883 0.345 7 2 yes Yes, low Non-
mutagen 
2b 
 
 
475.52 -6.406 2 2 5.666 0.298 8 2 yes Yes, Low Non-
mutagen 
2c 491.52 -5.931 2 2 5.163 0.308 8 2 No Yes, low Non-
mutagen 
2d 495.94 -6.731 1 2 5.844 0.298 7 2 No Yes, low Non-
mutagen 
2e 507.50 -5.046 1 2 6.161 0.299 7 2 no Yes, low Non-
mutagen 
2f 511.55 -6.97 1 2 6.088 0.285 7 2 No Extremel
y low 
Non-
mutagen 
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Table 6: Details of interactions in most stable protein-ligand complex for 1 and 2a to f.  
Compounds Hydrogen bonds Pi bond 
NO. 
of H-
bond 
End 1 End2 Bond 
distance 
Angle 
DHA 
 
 
 
 
3TZF@1 4 Lys221(NH) Carbonyl O of 
salicylaldehyde. 
1.88 150   
Ser222(O) HN of 
sulfonamide 
moiety 
2.87 91   
Arg255(HN) O of 
salicylaldehyde 
2.20 114   
Arg255(HN) O of 
salicylaldehyde 
2.99 110   
 3TZF@2a  1 Ser222(NH) N of azo 2.69 135 4.36 Pro64 nucleus 
of  oxazole ring 
to 
salicylaldehyde 
ring 
  
Lys221(CH) 
 
N of imine 2.69 157 
 Leu194(NH) O of SO2 2.10 145 
Asn193(CH) O of SO2 2.59 113 
3TZF@2b  2 Gly139(C=O) N of Azo 3.39 147 5.11 Pro64 nucleus 
of  oxazole ring 
to 
salicylaldehyde 
ring 
Thr62(HO) HO of 
Salicylaldehyde 
2.02 177 4.93 Phe28 nucleus 
of benzene ring 
to  
salicylaldehyde  
nucleus 
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   (a)       (b) 
Fig. 5. Best fit binding of 1 in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
3TZF@2c 3 Gly189(O) OH of 
salicylaldehyde 
moiety 
3.02 117   
Arg255(NH) O of OCH3 2.03 148 
3TZF@2d 1 Arg255(NH) O of oxazole 
moiety 
2.83 121 3.80 ThrO...nucleus 
of oxazole ring 
3TZF@2e 
 
 
4 
Thr62(HN) O of SO2 of SMX 2.81 155  
5.28 
Phe190 nucleus 
of benzene  to 
oxazole ring of 
SMX 
Thr62(OH) HN of SO2 2.72 154 
Arg255(NH) O  of SO2 1.74 142 
2.14 129 
3TZF@2f 2 ARG135(NH) O of SO2NH 1.98 134   
 GLy189(O) HO of 
salicylaldehyde 
moiety 
2.06 152 3.17 ThrNH...nucleas 
of 
naphthaldehyde 
moeity 
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   (a)      (b) 
Fig. 6. Best fit binding of 2a in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
 
   (a)      (b) 
Fig. 7. Best fit binding of 2b in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
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   (a)      (b) 
Fig. 8. Best fit binding of 2c in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
 
   (a)      (b) 
Fig. 9. Best fit binding of 2d in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
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   (a)      (b) 
Fig. 10. Best fit binding of 2e in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
 
   (a)      (b) 
Fig. 11. Best fit binding of 2f in the DHPS (PDB id 3TZF) cavity; (a) 2D interaction and (b) 3D 
interaction 
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3.6. Theoretical interpretation of electronic spectra  
The DFT computation technique is used to optimize the structure of the ligands. The bond 
distances and angles have been verified by the comparing between the DFT optimized and X-ray 
determined structures (Table 2).  To simplify analysis of DFT computation result the structure of the 
ligand has been divided into azo, benzene sulfonamide (BSN), methyloxazolyl (MOX) and 
salicylaldehyde and  aniline, p-toluidine, p-methoxyaniline, p-chloroaniline, p-nitroaniline, α-
naphthylamine  (Supplementary Material, Figs. S22 – S28). Theoretically generated structures of the 
ligands are used to calculate data and energy of the functions. The electronic properties of these 
molecules have also been verified by DFT data (Supplementary Materials, Figs. Tables S1-S14). The 
HOMO of 1 is constituted by  salicylaldehyde (84%) , azo (6%), benzsulfonamide  (9%)  and 
oxazole (1%), where as 2a is constituted by  aniline (54%), azo (3%), benzsulfonamide  (3%) , 
salicylaldehyde  (60 %); 2b is comprising  toluidine (52%), azo (6%), benzsulfonamide  (10%), 
salicylaldehyde  (31%); 2c is made up of  p-methoxyaniline (65%), azo (1%), benzsulfonamide  
(1%), salicylaldehyde  (33%); 2d is composed of  p-chloroaniline (55%), azo (3%), 
benzsulfonamide  (6%), salicylaldehyde  (36%); 2e is formed by  p-nitroaniline (22%), azo (8%), 
benzsulfonamide  (1%), salicylaldehyde  (66%); 2f invol by  α-naphthylamine (89%), azo (1%), 
and salicylaldehyde  (10%).  
The electronic transitions have been explained by the population of occupied MOs and 
unoccupied MOs. The intensity of these transitions has been assessed from oscillator strength (f).  The 
ligands show transitions between different molecular fragments, viz., HOMO → LUMO, 458.14 nm (f, 
0.915); HOMO-5 →LUMO, 319.3 nm (f, 0.2224) are considered as admixture of salicylaldehyde to 
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benzsulfonamide, azo charge transitions, whereas most of the accepted transitions 
(Supplementary Materials, Tables S1-S14) are intra-ligand charge transfer transitions.  
 
1 
(a) 
 
      (b) 
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       (c) 
Fig. 12. The HOMO–LUMO  energy gap and corelation diagram of 1 and the azo-imine 
derivatives, 2. 
 
Conclusion 
In Twenty first century discovery of new antibiotic is a challenging task. At present a 
strategy is the functionalization of formerly useful drugs for the making of less toxic more 
efficient molecule. Sulfamethoxazole is used to synthesize azo and azo-mine functionalized 
molecules such as  [SMX-N=N-C6H3-(p-OH)(m-CHO)] (1) and [SMX-N=N-C6H3-(p-OH)(m-
HC=N-Ar)] (2) (Ar = –C6H5 (2a), –C6H4-p-CH3 (2b), –C6H4-p-OCH3 (2c), –C6H4-p-Cl (2d), –
C6H4-p-NO2 (2e), –C10H7 (2f)).  The antibacterial properties of the compounds have been 
evaluated against Gram positive bacteria, B. subtillis and Gram negative bacteria, E. coli. Cell 
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line toxicity in Vero cells and anti-viral activity against harpies’ virus (HSV-1F ATCC-733) are 
examined. Data reveal that [SMX-N=N-C6H3-(p-OH)(m-CHO)] (1) becomes the most efficient 
drug against B. subtillis and also active against HSV-1F infection. In silico Docking has been 
examined by using DFT optimized and X-ray structures of all these molecules with active site 
residue of DHPS (dihydropteroate synthetase) protein (downloaded from PDB file) to search the 
most favored binding mode of the drugs and hence their competitive drug efficiency. The MTT 
assay represents the toxicity of the products, 1 and 2a-f, are quite less where as the activity 
against gram +ve bacteria is around 3 times more for 1 derivative and for 2a-f  are also lower 
than that of SMX. 
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